1. Carnosic acid increases sorafenib-induced inhibition of ERK1/2 and STAT3 signaling which contributes to reduced cell proliferation and survival of Hepatocellular carcinoma cells
   Xuening Wang et al, 2020, Oncotarget CrossRef
2. Preparation, Evaluation and In vitro Cytotoxicity Studies of Artesunate-loaded Glycyrrhetinic Acid Decorated PEG-PLGA Nanoparticles
   Xuwang Pan et al, 2020, Drug Development and Industrial Pharmacy CrossRef
3. Synergistic Effects of Ellagic Acid and Sorafenib on Hepatocytes and Mitochondria Isolated from a Hepatocellular Carcinoma Rat Model
   Ahmad Salimi et al, 2020, Nutrition and Cancer CrossRef
4. Artesunate Impairs Growth in Cisplatin-Resistant Bladder Cancer Cells by Cell Cycle Arrest, Apoptosis and Autophagy Induction.
   Fuguang Zhao et al, 2020, Cells CrossRef
5. A Network Pharmacology Approach to Reveal the Underlying Mechanisms of Artemisia annua on the Treatment of Hepatocellular Carcinoma
   Shuqiao Zhang et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
6. Combination of Wogonin and Artesunate Exhibits Synergistic anti-Hepatocellular Carcinoma Effect by Increasing DNA-Damage-Inducible Alpha, Tumor Necrosis Factor α and Tumor Necrosis Factor Receptor-Associated Factor 3-mediated Apoptosis.
   Minting Chen et al, 2021, Front Pharmacol CrossRef
7. Artesunate Inhibits the Growth Behavior of Docetaxel-Resistant Prostate Cancer Cells.
   Olesya Vakhrusheva et al, 2022, Front Oncol CrossRef
8. Artemisinins in Combating Viral Infections Like SARS-CoV-2, Inflammation and Cancers and Options to Meet Increased Global Demand
   Karim Farmanpour-Kalalagh et al, 2022, Front. Plant Sci. CrossRef